For the Inventor, By the Inventor

Enter assignee name

Ewing, NJ, United States of America

Antares Pharma, Inc.

USPTO Granted Patents = 110

CIPO Patents = 5

EPO Patents = 24

Trademarks = 7

Forward Citations = 2,418

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Peter L Sadowski (44 out of 49 patents)

Paul R Lesch, Jr (28 out of 36 patents)

Julius Craig Sund (27 out of 29 patents)

4. Matthew Rust (23 out of 36 patents)

5. Peter A Hoeft (23 out of 27 patents)

6. Thomas Edward KraMer (23 out of 41 patents)

7. Paul K Wotton (17 out of 17 patents)

8. Patrick Madsen (14 out of 15 patents)

9. Michael Travanty (13 out of 17 patents)

10. Paul M Goudreau (12 out of 20 patents)

11. Kevin David Swanson (12 out of 22 patents)

12. John William Hayes (11 out of 11 patents)

13. Claude L Berman (9 out of 11 patents)

14. Kaushik J Dave (8 out of 12 patents)

15. Janice Cox (7 out of 9 patents)

Core Competencies:

Injector

Prefilled Syringe

Needle Assisted Injection

Testosterone Formulations

Hazardous Agent Injection

Variable Dosing Injection Device

Auto-Insert Injector

Injection Device Safety

Jet Injection Administration

Two-Stage Reconstituting Injector

Cartridge Retainer

Syringe Shock Absorber

110 patents: Sort by Forward Citations

1. 12453819 - Injector (2025-10-28),

2. 12409272 - Prefilled syringe with breakaway force feature (2025-09-09),

3. 12357642 - Hazardous agent injection system (2025-07-15),

4. 12318581 - Needle assisted injection device having reduced trigger force (2025-06-03),

5. 12220560 - Needle assisted injection device having reduced trigger force (2025-02-11),

6. 12179007 - Injection device with cammed ram assembly (2024-12-31),

7. 12171986 - Injection device with cammed ram assembly (2024-12-24),

8. 12144817 - Testosterone ester triglyceride formulations (2024-11-19),

9. 12121704 - Injector with adjustable dosing (2024-10-22),

10. 12102643 - Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol (2024-10-01),

11. 11878156 - Injection device (2024-01-23),

12. 11857555 - Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol (2024-01-02),

13. 11850401 - Auto-insert injector (2023-12-26),

14. 11844804 - Administration of testosterone compositions (2023-12-19),

15. 11813435 - Needle assisted injection device having reduced trigger force (2023-11-14),

Antares Pharma is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products. Their product portfolio includes autoinjectors, pen injectors, nasal sprays, and transdermal gel technologies. Antares Pharma's innovative drug delivery systems help improve patient compliance and convenience. They collaborate with pharmaceutical partners to bring advanced therapeutic solutions to market.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

110 Patents

#2 in Ewing, NJ

#159 in New Jersey

#3,344 in US

#6,950 in the World

Ewing, NJ, United States of America

Antares Pharma, Inc.

Forward Citations = 2,418

46 inventors:

Peter L Sadowski (44 out of 49 patents)

Paul R Lesch, Jr (28 out of 36 patents)

Julius Craig Sund (27 out of 29 patents)

4. Matthew Rust (23 out of 36 patents)

5. Peter A Hoeft (23 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…